Cover Image
QR Code

Managing mRNA Instability During Formulation, Manufacturing, and Shipment: Unique solutions are required to protect inherently unstable messenger RNA.

Published in:Pharmaceutical Technology Europe Vol. 34; no. 12; pp. 14 - 17
Main Author: Challener, Cynthia A.
Format: pictorial Journal Article
Published: MJH Life Sciences Dec2022
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160763700&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 160763700
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17537967
        5NG
      jtl: Pharmaceutical Technology Europe
      issn: 17537967
      maglogo: N
    pubinfo:
      dt: Dec2022
      vid: 34
      iid: 12
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        160763700
        160763700
        160763700
        160763700
      ppf: 14
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Managing mRNA Instability During Formulation, Manufacturing, and Shipment: Unique solutions are required to protect inherently unstable messenger RNA.
      aug:
        au: Challener, Cynthia A.
      sug:
        subj:
          RNA, Messenger Therapeutic Use
          Drug Storage
          Chemistry, Pharmaceutical
          Drug Development
          Nucleotides Therapeutic Use
          Freeze Drying
          Technology, Pharmaceutical
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N